PMID: 8939638Dec 1, 1996Paper

Therapeutic targets in cardiovascular disorders

Current Opinion in Biotechnology
W Schaper, W D Ito

Abstract

The feasibility of gene therapy for cardiovascular diseases related to atherosclerosis is a topic that needs to be addressed. Most recent papers have dealt with technical aspects and feasibility and most of the genes transferred were reporter genes like those for beta-galactosidase or luciferase. This may mean that the ideal vector, one that is not pathogenic or immunotolerant but is still efficient, is still not available. The results of these studies are ambiguous and it has been doubted whether the genes targeted really affect the disease. Further efforts are therefore needed to elucidate the underlying pathophysiology.

Citations

Jul 6, 2000·Journal of Psychosomatic Research·J R Swenson, J J Clinch
Dec 28, 2002·Psychological Assessment·Carolyn Cook GotayIan S Pagano
Sep 9, 2009·Nature Reviews. Cardiology·Joanna J WykrzykowskaRobert S Schwartz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Dobbels FabienneMeyns Bart
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
K L GradyJames K Kirklin
© 2021 Meta ULC. All rights reserved